Bryan Giraudo, Director at Protagonist Therapeutics, Inc (PTGX), bought 8,000 shares at $5.70 ($46K) on 2019-12-03, disclosed to the SEC on 2019-12-03.
Open-market purchase of $46k PTGX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |
| GOSS | SELL | 2024-03-28 | $7K | — | Filing → |
| GOSS | BUY | 2023-11-14 | $224K | — | Filing → |
| GOSS | BUY | 2023-04-05 | $56K | — | Filing → |